Form 4 for GEHC GE HealthCare
Accepted 2023-01-05 00:00:00 ET · period of report 2023-01-03 · accession 0000899243-23-001100 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2023-01-05 | 2023-01-03 | GEHC | Newcomb George A. | CAO | A - Grant | — | +155 | 12 | New | — |
| D | 2023-01-05 | 2023-01-03 | GEHC | Newcomb George A. | CAO | A - Grant | — | +439 | 439 | New | — |
| DM | 2023-01-05 | 2023-01-03+ | GEHC | Newcomb George A. | CAO | A - Grant | — | +49.6K | 3,672 | New | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock, par value $0.01 per share | 2023-01-03 | A | A | 143 | — | 143 | I | — | — | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. |
| 2 | Common | Common stock, par value $0.01 per share | 2023-01-03 | A | A | 12 | — | 12 | I 401(k) | — | — | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. |
| 3 | Common | Common stock, par value $0.01 per share | 2023-01-03 | A | A | 439 | — | 439 | D By family member | — | — | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. |
| 4 | Derivative | Restricted Stock Units | 2023-01-04 | A | A | 2,599 | — | 2,599 | D | — · — to — | 2,599 Common stock, par value $0.01 per share | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. (F6) Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. (F8) Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2023 and 50% will vest on March 1, 2024. |
| 5 | Derivative | Employee Stock Option (right to buy) | 2023-01-04 | A | A | 4,592 | — | 4,592 | D | $161.30 · — to 2026-09-30 | 4,592 Common stock, par value $0.01 per share | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. (F2) Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately. |
| 6 | Derivative | Restricted Stock Units | 2023-01-04 | A | A | 2,549 | — | 2,549 | D | — · — to — | 2,549 Common stock, par value $0.01 per share | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. (F6) Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. (F9) Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2024 and 50% will vest on March 1, 2025. |
| 7 | Derivative | Restricted Stock Units | 2023-01-04 | A | A | 1,261 | — | 1,261 | D | — · — to — | 1,261 Common stock, par value $0.01 per share | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. (F6) Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. (F7) Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% will vest on March 2, 2023. |
| 8 | Derivative | Deferred Bonus Phantom Stock Units | 2023-01-03 | A | A | 28 | — | 28 | D | — · — to — | 28 Common stock, par value $0.01 per share | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. (F4) Each unit of phantom stock is the economic equivalent of one share of GE HealthCare common stock. (F5) Award of phantom stock with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off. Payable after termination of service. This transaction is being reported notwithstanding the exemption provided by Rule 16a-9. |
| 9 | Derivative | Employee Stock Option (right to buy) | 2023-01-04 | A | A | 2,434 | — | 2,434 | D | $99.21 · — to 2027-11-17 | 2,434 Common stock, par value $0.01 per share | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. (F2) Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately. |
| 10 | Derivative | Employee Stock Option (right to buy) | 2023-01-04 | A | A | 8,416 | — | 8,416 | D | $63.51 · — to 2030-03-02 | 8,416 Common stock, par value $0.01 per share | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. (F3) Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% is exercisable immediately and 50% will become exercisable on March 2, 2023. |
| 11 | Derivative | Employee Stock Option (right to buy) | 2023-01-04 | A | A | 3,229 | — | 3,229 | D | $51.67 · — to 2029-04-11 | 3,229 Common stock, par value $0.01 per share | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. (F2) Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately. |
| 12 | Derivative | Employee Stock Option (right to buy) | 2023-01-04 | A | A | 6,835 | — | 6,835 | D | $57.74 · — to 2029-03-19 | 6,835 Common stock, par value $0.01 per share | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. (F2) Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately. |
| 13 | Derivative | Employee Stock Option (right to buy) | 2023-01-04 | A | A | 6,638 | — | 6,638 | D | $40.40 · — to 2028-12-21 | 6,638 Common stock, par value $0.01 per share | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. (F2) Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately. |
| 14 | Derivative | Employee Stock Option (right to buy) | 2023-01-04 | A | A | 3,672 | — | 3,672 | D | $129.52 · — to 2023-09-13 | 3,672 Common stock, par value $0.01 per share | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. (F2) Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately. |
| 15 | Derivative | Employee Stock Option (right to buy) | 2023-01-04 | A | A | 3,672 | — | 3,672 | D | $142.15 · — to 2024-09-05 | 3,672 Common stock, par value $0.01 per share | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. (F2) Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately. |
| 16 | Derivative | Employee Stock Option (right to buy) | 2023-01-04 | A | A | 3,672 | — | 3,672 | D | $135.92 · — to 2025-09-11 | 3,672 Common stock, par value $0.01 per share | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. (F2) Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately. |